The current financial position of Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock

Total assets of CYCCP for Q1 24 is 6.17 M USD, 29.98% less than the previous Q4 23. And total liabilities increased by 2.11% in Q1 24 to 8.37 M USD.